BioSpace News Archive

Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today a presentation describing use of the Company’s proprietary Discovery Engine, featuring the Company’s Immune Repertoire Capture® (IRC™) technology,

Collaboration combines Mission’s unique science, chemistry and proprietary enzyme platform with AbbVie’s strong neurodegenerative disease research, development and commercialisation capabilities

TWi Biotechnology, Inc. announced today that it has completed patient enrollment in its Phase 2 clinical trial (Study code: AC-201CR-HA-001) of AC-201CR for the treatment of hemophilic arthropathy.

12 Sigma Technologies, developer of world-leading medical imaging solutions inspired by artificial intelligence and deep learning, will introduce four(4) new CAD products at RSNA 2018.

MediSapiens has partnered with Terveystalo, a leading private healthcare service provider in Finland, to support their biobank operations with scalable, interactive and secure genomic and clinical data solutions.

Supports Near-term Initiation of Phase 2 Essential Tremor and Spinocerebellar Ataxia Trials

Investments will enhance customer experience and specialty transportation services through advanced technology solutions

Fina Biosolutions LLC announced today it has reached agreement with PATH, a global organization focused on solving some of the world’s most pressing health challenges, under which PATH will provide funding and technical support for the clinical manufacture of FinaBio’s CRM197, known commercially as EcoCRM®.

Immunomic Therapeutics, Inc. (ITI) announced today that the company will present and participate at the 2018 World Vaccine & Immunotherapy Congress West Coast, being held November 28-29 in San Diego, CA.

Maxim Healthcare Services Chief Medical Officer John Langley, M.D., has been elected to chair the American Academy of Pediatrics’ (AAP) Section on Home Care (SOHC).